Hyperlipidaemia and cardiovascular disease.

Suppr

超能文献

作者信息

Buchalter M

出版信息

Curr Opin Lipidol. 1997 Jun;8(3):U40-1. doi: 10.1097/00041433-199706000-00016.

DOI:10.1097/00041433-199706000-00016

PMID:9211073

Abstract

摘要

相似文献

Hyperlipidaemia and cardiovascular disease.

Curr Opin Lipidol. 1997 Jun;8(3):U40-1. doi: 10.1097/00041433-199706000-00016.

Implications of 4S evidence on baseline lipid levels.

Lancet. 1995 Jul 15;346(8968):181.

Implications of 4S evidence on baseline lipid levels.

Lancet. 1995 Jul 15;346(8968):181-2.

Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.

J Clin Pharm Ther. 1994 Dec;19(6):387-9. doi: 10.1111/j.1365-2710.1994.tb00698.x.

Implications of 4S evidence on baseline lipid levels.

Lancet. 1995 Jul 15;346(8968):181.

Hyperlipidaemia and cardiovascular disease.

Curr Opin Lipidol. 1995 Dec;6(6):U160-4. doi: 10.1097/00041433-199512000-00015.

[Limitations of interventions against hypercholesterolemia].

Aten Primaria. 1996 Mar 15;17(4):305-6.

Cholesterol synthesis inhibitors in hyperlipidaemia.

Lancet. 1988 Mar 12;1(8585):597. doi: 10.1016/s0140-6736(88)91401-8.

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

Am J Cardiol. 2003 Mar 15;91(6):667-72. doi: 10.1016/s0002-9149(03)00007-9.

Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.

Lancet. 1988 Dec 10;2(8624):1335-8. doi: 10.1016/s0140-6736(88)90870-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验